Pluristem Therapeutics (PSTI) And The Alliance For Regenerative Medicine Advocate For Industry Advancement In Washington D.C.
4/22/2014 9:02:29 AM
HAIFA, Israel, April 22, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that Company executives are actively participating in a series of meetings in Washington D.C. regarding proposed legislation that may impact the future of cell therapy and regenerative medicine in the U.S.
Help employers find you! Check out all the jobs and post your resume.
comments powered by